Table of Contents Table of Contents
Previous Page  244 / 1096 Next Page
Information
Show Menu
Previous Page 244 / 1096 Next Page
Page Background

S231

ESTRO 36

_______________________________________________________________________________________________

The influence of the MRL fringe field is less than described

by Kok for the pre-clinical prototype, but does still

influence the beam steering of the accelerators in

adjacent treatment rooms. The LUTs of 2 accelerators,

that were situated the closest to the MRL, but outside the

0.5 Gauss line, needed to be adjusted in order to get beam

parameters within tolerances. Adjusting the LUTs fully

corrected the influence of the magnetic fringe field of the

MRL. In case of an unexpected ramp down of the magnet

(i.e. quench) both neighbouring accelerators cannot be

used clinically before the LUTs are adjusted to the new

situation. Adjustment of the LUT can be done in a short

time by experienced personnel, without a dedicated

measurement

device.

References:

Kok et al., Phys. Med. Biol.

54

(2009) N409–N415

OC-0439 Treating patients with Dynamic Wave Arc: first

clinical experience

M. Burghelea

1

, D. Verellen

2

, J. Dhont

1

, C. Hung

3

, K.

Poels

4

, R. Van den Begin

1

, M. Boussaer

1

, K. Tournel

1

, C.

Jaudet

1

, T. Reynders

1

, T. Gevaert

1

, V. Simon

5

, M. De

Ridder

1

1

Universitair Ziekenhuis Brussel- Vrije Universiteit

Brussel, Department of Radiotherapy, Brussels, Belgium

2

GZA Ziekenhuizen- Sint Augustinus – Iridium

Kankernetwerk Antwerpen, Radiotherapy Department,

Antwerpen, Belgium

3

Brainlab AG- Feldkirchen- Germany, R&D RT Motion

Management, Munich, Germany

4

University Hospitals Leuven, Department of Radiation

Oncology, Leuven, Belgium

5

Babes Bolyai University, Faculty of Physics, Cluj-

Napoca, Romania

Purpose or Objective

Dynamic Wave Arc (DWA) is a system-specific non-

coplanar arc technique that combines synchronized

gantry-ring rotation with D-MLC optimization. This paper

presents the clinical workflow, quality assurance program,

and reports the geometric and dosimetric results of the

first patient cohort treated with DWA.

Material and Methods

The RayStation TPS was clinically integrated on the Vero

SBRT platform for DWA treatments. The main difference

in the optimization modules of VMAT and DWA relates to

angular spacing, where the DWA optimization algorithm

does not consider the gantry spacing, but only the

Euclidian norm of the ring and gantry angle. To support

DWA deliveries, the Vero system required some additional

upgrades: an MLC secondary feedback unit upgrade

allowing faster dynamic MLC leaf movement of up to 4

cm/s at isocenter level, and a machine controller offering

gantry-ring synchronous rotations.

The first 15 patients treated with DWA represent a broad

range of treatment sites: breast boost, prostate, lung

SBRT and bone metastases, which allowed us to explore

the potentials and assess the limitations of the current

site-specific DWA template solution. Table 1 provides

further information for each patient case including the

corresponding DWA plan information, while Figure 1

presents the most common used DWA trajectories. For the

DWA verification a variety of QA equipment was used,

from 3D diode array to an anthropomorphic end-to-end

phantom. The geometric accuracy of each arc was verified

with an in-house developed method using fluoroscopy

images.